CK effective over the long-term

Article

Conductive keratoplasty (CK) is an effective long-term treatment for near-plano presbyopia.

Conductive keratoplasty (CK) is an effective long-term treatment for near-plano presbyopia, according to the results of a study published in the November issue of the Journal of Refractive Surgery.

Jason Stahl, MD from Kansas University Medical Center, Kansas, US evaluated the outcomes of 10 patients treated with unilateral CK, performed using the ViewPoint CK system (Refractec). Nine patients were available for follow-up at three years.

Preoperatively, the average manifest refraction spherical equivalent (MRSE) was -0.17 D and average near uncorrected visual acuity (UCVA) was J10. At three years follow-up, the mean MRSE had decreased to -1.06 D, representing a 0.25 D change from the average MRSE of -1.31 D at one year follow-up. Furthermore, at three years, all subjects had maintained an uncorrected binocular distance visual acuity of 20/20 and near UCVA averaged J3 or better in 78% of subjects.

Dr Stahl concluded that CK can be an effective long-term treatment for presbyopia.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.